Results 101 to 110 of about 22,008 (204)
The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui +11 more
wiley +1 more source
This single‐center retrospective study of pediatric solid organ transplant recipients found that vaccine‐specific serologies were rarely utilized to guide post‐transplant vaccination practices. Additionally, older age at the time of transplant, private insurance, and heart transplantation were identified as risk factors for delayed and incomplete non ...
Adam Z. Blatt +3 more
wiley +1 more source
Respirology, Volume 31, Issue 3, Page 232-235, March 2026.
Takashi Hirama +2 more
wiley +1 more source
Pneumococcus Diagnostic Serum [PDF]
openaire +2 more sources
Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: Results. [PDF]
Wyss F +31 more
europepmc +1 more source
High-resolution genomics uncovers region-specific evolution and virulence of ocular <i>Streptococcus pneumoniae</i>. [PDF]
Xiang X +14 more
europepmc +1 more source
No culture? No problem: Clinical utility and pitfalls of non-culture diagnostics for pneumococcal parapneumonic effusions. [PDF]
Dimeas IE +3 more
europepmc +1 more source
Editorial: Molecular Pathogenesis of Pneumococcus
Guangchun Bai +2 more
doaj +1 more source
The influence of pneumococcal positivity on clinical outcomes among patients hospitalized with COVID-19: A retrospective cohort study. [PDF]
Yoon CS +9 more
europepmc +1 more source

